[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Non-Radioactive Nucleic Acid Labeling Product Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030

April 2024 | 129 pages | ID: G5206B666EAEEN
APO Research

US$ 3,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In recent years, non-radioactive nucleic acid labeling and detection methodologies have become available in response to a desire by researchers and their institutions to move away from the use of radioisotopes. Advancements made in the areas of chemiluminescence and fluorescence have allowed for an easier transition. In non-radioactive assays, signal is generated through an enzymatic reaction with a chemiluminescent or chromogenic substrate; alternatively, detection can occur through the appropriate excitation and emission of a fluorophore-labeled probe.

According to APO Research, The global Non-Radioactive Nucleic Acid Labeling Product market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Global Non-Radioactive Nucleic Acid Labeling Product key players include Thermo Fisher Scientific, Roche, Promega, etc. Global top three manufacturers hold a share over 40%.

United States is the largest market, with a share over 40%, followed by China

and Europe, both have a share about 35 percent.

In terms of product, DIG System is the largest segment, with a share about 33%. And in terms of application, the largest application is DNA Labeling, followed by RNA Labeling, Oligonucleotide Labeling.

This report presents an overview of global market for Non-Radioactive Nucleic Acid Labeling Product, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Non-Radioactive Nucleic Acid Labeling Product, also provides the sales of main regions and countries. Of the upcoming market potential for Non-Radioactive Nucleic Acid Labeling Product, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Non-Radioactive Nucleic Acid Labeling Product sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Non-Radioactive Nucleic Acid Labeling Product market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Non-Radioactive Nucleic Acid Labeling Product sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Thermo Fisher Scientific, Roche, Promega, PerkinElmer, Agilent Technologies, General Electric, Enzo Biochem, Merck KGaA and Vector Labs, etc.

Non-Radioactive Nucleic Acid Labeling Product segment by Company
  • Thermo Fisher Scientific
  • Roche
  • Promega
  • PerkinElmer
  • Agilent Technologies
  • General Electric
  • Enzo Biochem
  • Merck KGaA
  • Vector Labs
  • New England Biolabs
Non-Radioactive Nucleic Acid Labeling Product segment by Type
  • Biotin
  • DIG System
  • Fluorescent
  • Others
Non-Radioactive Nucleic Acid Labeling Product segment by Application
  • DNA Labeling
  • RNA Labeling
  • Oligonucleotide Labeling
Non-Radioactive Nucleic Acid Labeling Product segment by Region
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • China Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-Radioactive Nucleic Acid Labeling Product market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-Radioactive Nucleic Acid Labeling Product and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-Radioactive Nucleic Acid Labeling Product.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Non-Radioactive Nucleic Acid Labeling Product market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Non-Radioactive Nucleic Acid Labeling Product manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Non-Radioactive Nucleic Acid Labeling Product in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Non-Radioactive Nucleic Acid Labeling Product in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report
1 MARKET OVERVIEW

1.1 Product Definition
1.2 Global Non-Radioactive Nucleic Acid Labeling Product Market Size, 2019 VS 2023 VS 2030
1.3 Global Non-Radioactive Nucleic Acid Labeling Product Market Size Estimates and Forecasts (2019-2030)
1.4 Global Non-Radioactive Nucleic Acid Labeling Product Sales Estimates and Forecasts (2019-2030)
1.5 Global Non-Radioactive Nucleic Acid Labeling Product Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives

2 GLOBAL NON-RADIOACTIVE NUCLEIC ACID LABELING PRODUCT MARKET DYNAMICS

2.1 Non-Radioactive Nucleic Acid Labeling Product Industry Trends
2.2 Non-Radioactive Nucleic Acid Labeling Product Industry Drivers
2.3 Non-Radioactive Nucleic Acid Labeling Product Industry Opportunities and Challenges
2.4 Non-Radioactive Nucleic Acid Labeling Product Industry Restraints

3 NON-RADIOACTIVE NUCLEIC ACID LABELING PRODUCT MARKET BY MANUFACTURERS

3.1 Global Non-Radioactive Nucleic Acid Labeling Product Revenue by Manufacturers (2019-2024)
3.2 Global Non-Radioactive Nucleic Acid Labeling Product Sales by Manufacturers (2019-2024)
3.3 Global Non-Radioactive Nucleic Acid Labeling Product Average Sales Price by Manufacturers (2019-2024)
3.4 Global Non-Radioactive Nucleic Acid Labeling Product Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Non-Radioactive Nucleic Acid Labeling Product Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Non-Radioactive Nucleic Acid Labeling Product Manufacturers, Product Type & Application
3.7 Global Non-Radioactive Nucleic Acid Labeling Product Manufacturers Commercialization Time
3.8 Market Competitive Analysis
  3.8.1 Global Non-Radioactive Nucleic Acid Labeling Product Market CR5 and HHI
  3.8.2 Global Top 5 and 10 Non-Radioactive Nucleic Acid Labeling Product Players Market Share by Revenue in 2023
  3.8.3 2023 Non-Radioactive Nucleic Acid Labeling Product Tier 1, Tier 2, and Tier

4 NON-RADIOACTIVE NUCLEIC ACID LABELING PRODUCT MARKET BY TYPE

4.1 Non-Radioactive Nucleic Acid Labeling Product Type Introduction
  4.1.1 Biotin
  4.1.2 DIG System
  4.1.3 Fluorescent
  4.1.4 Others
4.2 Global Non-Radioactive Nucleic Acid Labeling Product Sales by Type
  4.2.1 Global Non-Radioactive Nucleic Acid Labeling Product Sales by Type (2019 VS 2023 VS 2030)
  4.2.2 Global Non-Radioactive Nucleic Acid Labeling Product Sales by Type (2019-2030)
  4.2.3 Global Non-Radioactive Nucleic Acid Labeling Product Sales Market Share by Type (2019-2030)
4.3 Global Non-Radioactive Nucleic Acid Labeling Product Revenue by Type
  4.3.1 Global Non-Radioactive Nucleic Acid Labeling Product Revenue by Type (2019 VS 2023 VS 2030)
  4.3.2 Global Non-Radioactive Nucleic Acid Labeling Product Revenue by Type (2019-2030)
  4.3.3 Global Non-Radioactive Nucleic Acid Labeling Product Revenue Market Share by Type (2019-2030)

5 NON-RADIOACTIVE NUCLEIC ACID LABELING PRODUCT MARKET BY APPLICATION

5.1 Non-Radioactive Nucleic Acid Labeling Product Application Introduction
  5.1.1 DNA Labeling
  5.1.2 RNA Labeling
  5.1.3 Oligonucleotide Labeling
5.2 Global Non-Radioactive Nucleic Acid Labeling Product Sales by Application
  5.2.1 Global Non-Radioactive Nucleic Acid Labeling Product Sales by Application (2019 VS 2023 VS 2030)
  5.2.2 Global Non-Radioactive Nucleic Acid Labeling Product Sales by Application (2019-2030)
  5.2.3 Global Non-Radioactive Nucleic Acid Labeling Product Sales Market Share by Application (2019-2030)
5.3 Global Non-Radioactive Nucleic Acid Labeling Product Revenue by Application
  5.3.1 Global Non-Radioactive Nucleic Acid Labeling Product Revenue by Application (2019 VS 2023 VS 2030)
  5.3.2 Global Non-Radioactive Nucleic Acid Labeling Product Revenue by Application (2019-2030)
  5.3.3 Global Non-Radioactive Nucleic Acid Labeling Product Revenue Market Share by Application (2019-2030)

6 GLOBAL NON-RADIOACTIVE NUCLEIC ACID LABELING PRODUCT SALES BY REGION

6.1 Global Non-Radioactive Nucleic Acid Labeling Product Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Non-Radioactive Nucleic Acid Labeling Product Sales by Region (2019-2030)
  6.2.1 Global Non-Radioactive Nucleic Acid Labeling Product Sales by Region (2019-2024)
  6.2.2 Global Non-Radioactive Nucleic Acid Labeling Product Sales Forecasted by Region (2025-2030)
6.3 North America
  6.3.1 North America Non-Radioactive Nucleic Acid Labeling Product Sales Growth Rate by Country: 2019 VS 2023 VS 2030
  6.3.2 North America Non-Radioactive Nucleic Acid Labeling Product Sales by Country (2019-2030)
  6.3.3 U.S.
  6.3.4 Canada
6.4 Europe
  6.4.1 Europe Non-Radioactive Nucleic Acid Labeling Product Sales Growth Rate by Country: 2019 VS 2023 VS 2030
  6.4.2 Europe Non-Radioactive Nucleic Acid Labeling Product Sales by Country (2019-2030)
  6.4.3 Germany
  6.4.4 France
  6.4.5 U.K.
  6.4.6 Italy
  6.4.7 Netherlands
6.5 Asia Pacific
  6.5.1 Asia Pacific Non-Radioactive Nucleic Acid Labeling Product Sales Growth Rate by Country: 2019 VS 2023 VS 2030
  6.5.2 Asia Pacific Non-Radioactive Nucleic Acid Labeling Product Sales by Country (2019-2030)
  6.5.3 China
  6.5.4 Japan
  6.5.5 South Korea
  6.5.6 Southeast Asia
  6.5.7 India
  6.5.8 Australia
6.6 LAMEA
  6.6.1 LAMEA Non-Radioactive Nucleic Acid Labeling Product Sales Growth Rate by Country: 2019 VS 2023 VS 2030
  6.6.2 LAMEA Non-Radioactive Nucleic Acid Labeling Product Sales by Country (2019-2030)
  6.6.3 Mexico
  6.6.4 Brazil
  6.6.5 Turkey
  6.6.6 GCC Countries

7 GLOBAL NON-RADIOACTIVE NUCLEIC ACID LABELING PRODUCT REVENUE BY REGION

7.1 Global Non-Radioactive Nucleic Acid Labeling Product Revenue by Region
  7.1.1 Global Non-Radioactive Nucleic Acid Labeling Product Revenue by Region: 2019 VS 2023 VS 2030
  7.1.2 Global Non-Radioactive Nucleic Acid Labeling Product Revenue by Region (2019-2024)
  7.1.3 Global Non-Radioactive Nucleic Acid Labeling Product Revenue by Region (2025-2030)
  7.1.4 Global Non-Radioactive Nucleic Acid Labeling Product Revenue Market Share by Region (2019-2030)
7.2 North America
  7.2.1 North America Non-Radioactive Nucleic Acid Labeling Product Revenue (2019-2030)
  7.2.2 North America Non-Radioactive Nucleic Acid Labeling Product Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
  7.3.1 Europe Non-Radioactive Nucleic Acid Labeling Product Revenue (2019-2030)
  7.3.2 Europe Non-Radioactive Nucleic Acid Labeling Product Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
  7.4.1 Asia-Pacific Non-Radioactive Nucleic Acid Labeling Product Revenue (2019-2030)
  7.4.2 Asia-Pacific Non-Radioactive Nucleic Acid Labeling Product Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
  7.5.1 LAMEA Non-Radioactive Nucleic Acid Labeling Product Revenue (2019-2030)
  7.5.2 LAMEA Non-Radioactive Nucleic Acid Labeling Product Revenue Share by Country: 2019 VS 2023 VS 2030

8 COMPANY PROFILES

8.1 Thermo Fisher Scientific
  8.1.1 Thermo Fisher Scientific Comapny Information
  8.1.2 Thermo Fisher Scientific Business Overview
  8.1.3 Thermo Fisher Scientific Non-Radioactive Nucleic Acid Labeling Product Sales, Price, Revenue and Gross Margin (2019-2024)
  8.1.4 Thermo Fisher Scientific Non-Radioactive Nucleic Acid Labeling Product Product Portfolio
  8.1.5 Thermo Fisher Scientific Recent Developments
8.2 Roche
  8.2.1 Roche Comapny Information
  8.2.2 Roche Business Overview
  8.2.3 Roche Non-Radioactive Nucleic Acid Labeling Product Sales, Price, Revenue and Gross Margin (2019-2024)
  8.2.4 Roche Non-Radioactive Nucleic Acid Labeling Product Product Portfolio
  8.2.5 Roche Recent Developments
8.3 Promega
  8.3.1 Promega Comapny Information
  8.3.2 Promega Business Overview
  8.3.3 Promega Non-Radioactive Nucleic Acid Labeling Product Sales, Price, Revenue and Gross Margin (2019-2024)
  8.3.4 Promega Non-Radioactive Nucleic Acid Labeling Product Product Portfolio
  8.3.5 Promega Recent Developments
8.4 PerkinElmer
  8.4.1 PerkinElmer Comapny Information
  8.4.2 PerkinElmer Business Overview
  8.4.3 PerkinElmer Non-Radioactive Nucleic Acid Labeling Product Sales, Price, Revenue and Gross Margin (2019-2024)
  8.4.4 PerkinElmer Non-Radioactive Nucleic Acid Labeling Product Product Portfolio
  8.4.5 PerkinElmer Recent Developments
8.5 Agilent Technologies
  8.5.1 Agilent Technologies Comapny Information
  8.5.2 Agilent Technologies Business Overview
  8.5.3 Agilent Technologies Non-Radioactive Nucleic Acid Labeling Product Sales, Price, Revenue and Gross Margin (2019-2024)
  8.5.4 Agilent Technologies Non-Radioactive Nucleic Acid Labeling Product Product Portfolio
  8.5.5 Agilent Technologies Recent Developments
8.6 General Electric
  8.6.1 General Electric Comapny Information
  8.6.2 General Electric Business Overview
  8.6.3 General Electric Non-Radioactive Nucleic Acid Labeling Product Sales, Price, Revenue and Gross Margin (2019-2024)
  8.6.4 General Electric Non-Radioactive Nucleic Acid Labeling Product Product Portfolio
  8.6.5 General Electric Recent Developments
8.7 Enzo Biochem
  8.7.1 Enzo Biochem Comapny Information
  8.7.2 Enzo Biochem Business Overview
  8.7.3 Enzo Biochem Non-Radioactive Nucleic Acid Labeling Product Sales, Price, Revenue and Gross Margin (2019-2024)
  8.7.4 Enzo Biochem Non-Radioactive Nucleic Acid Labeling Product Product Portfolio
  8.7.5 Enzo Biochem Recent Developments
8.8 Merck KGaA
  8.8.1 Merck KGaA Comapny Information
  8.8.2 Merck KGaA Business Overview
  8.8.3 Merck KGaA Non-Radioactive Nucleic Acid Labeling Product Sales, Price, Revenue and Gross Margin (2019-2024)
  8.8.4 Merck KGaA Non-Radioactive Nucleic Acid Labeling Product Product Portfolio
  8.8.5 Merck KGaA Recent Developments
8.9 Vector Labs
  8.9.1 Vector Labs Comapny Information
  8.9.2 Vector Labs Business Overview
  8.9.3 Vector Labs Non-Radioactive Nucleic Acid Labeling Product Sales, Price, Revenue and Gross Margin (2019-2024)
  8.9.4 Vector Labs Non-Radioactive Nucleic Acid Labeling Product Product Portfolio
  8.9.5 Vector Labs Recent Developments
8.10 New England Biolabs
  8.10.1 New England Biolabs Comapny Information
  8.10.2 New England Biolabs Business Overview
  8.10.3 New England Biolabs Non-Radioactive Nucleic Acid Labeling Product Sales, Price, Revenue and Gross Margin (2019-2024)
  8.10.4 New England Biolabs Non-Radioactive Nucleic Acid Labeling Product Product Portfolio
  8.10.5 New England Biolabs Recent Developments

9 VALUE CHAIN AND SALES CHANNELS ANALYSIS

9.1 Non-Radioactive Nucleic Acid Labeling Product Value Chain Analysis
  9.1.1 Non-Radioactive Nucleic Acid Labeling Product Key Raw Materials
  9.1.2 Raw Materials Key Suppliers
  9.1.3 Manufacturing Cost Structure
  9.1.4 Non-Radioactive Nucleic Acid Labeling Product Production Mode & Process
9.2 Non-Radioactive Nucleic Acid Labeling Product Sales Channels Analysis
  9.2.1 Direct Comparison with Distribution Share
  9.2.2 Non-Radioactive Nucleic Acid Labeling Product Distributors
  9.2.3 Non-Radioactive Nucleic Acid Labeling Product Customers

10 CONCLUDING INSIGHTS

11 APPENDIX

11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
  11.5.1 Secondary Sources
  11.5.2 Primary Sources
11.6 Disclaimer


More Publications